By the way decan thats great news that Merck Sharp n Dome still have a interest in CVac through biomera. They will be watching closely then at PRR's progress and may look to swoop on Cvac and then the tables may turn and merck may pay prr a royalty. Sure they have enough money to make PRR an outright offer for CVac.
cheers..
- Forums
- ASX - By Stock
- martin rogers says cvac rights 100% prr
By the way decan thats great news that Merck Sharp n Dome still...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
31.0¢ | 31.5¢ | 30.8¢ | $177.1K | 567.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 166807 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 220452 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 166807 | 0.310 |
15 | 399259 | 0.305 |
9 | 95908 | 0.300 |
8 | 132426 | 0.295 |
10 | 155381 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 224199 | 15 |
0.320 | 224957 | 16 |
0.325 | 284518 | 11 |
0.330 | 114091 | 8 |
0.335 | 85704 | 7 |
Last trade - 11.21am 12/11/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online